TOI insider transaction filings
Oncology Institute, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-29. Screen TOI transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 13 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings by 1 insider — 51,000 shares, $272,970 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 1 filing by 1 insider — 23,452 shares, $150,340 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 17,974 shares @ $6.43 ($115,555) by Podnos Yale, filed 2026-07-16.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Chernett Jorey — 10% owner | 3 | 3 legs · 51,000 sh · $272,970 | — | — |
| Podnos Yale — Chief Medical Officer | 1 | — | 2 legs · 23,452 sh · $150,340 | 4 |
| STOLPER MARK — Director | 2 | — | — | 2 |
| TZOUMAKAS KIMBERLY JO — Director | 2 | — | — | 2 |
| Hively Brad — Director | 1 | — | — | 1 |
| Johnson Karen Marie — Director | 1 | — | — | 1 |
| Kaushal Mohit — Director | 1 | — | — | 1 |
| McGeorge Anne — Director | 1 | — | — | 1 |
| Pacala Mark L — Director | 1 | — | — | 1 |
Recent Form 4 filings — Oncology Institute, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-29 | 4 | Kaushal Mohit — Director | Grant/award (A): 33,133 @ $0 | EDGAR |
| 2026-07-29 | 4 | McGeorge Anne — Director | Grant/award (A): 41,165 @ $0 | EDGAR |
| 2026-07-29 | 4 | STOLPER MARK — Director | Grant/award (A): 31,124 @ $0 | EDGAR |
| 2026-07-29 | 4 | Pacala Mark L — Director | Grant/award (A): 30,120 @ $0 | EDGAR |
| 2026-07-29 | 4 | TZOUMAKAS KIMBERLY JO — Director | Grant/award (A): 29,116 @ $0 | EDGAR |
| 2026-07-29 | 4 | Hively Brad — Director | Grant/award (A): 27,108 @ $0 | EDGAR |
| 2026-07-29 | 4 | Johnson Karen Marie — Director | Grant/award (A): 31,124 @ $0 | EDGAR |
| 2026-07-22 | 4 | Chernett Jorey — 10% owner | Purchase (P): 18,000 @ $5.27 | EDGAR |
| 2026-07-16 | 4 | Podnos Yale — Chief Medical Officer | Option exercise (M): 17,974 @ $1.87 · Sale (S): 17,974 @ $6.43 · Option exercise (M): 5,478 @ $2 · Sale (S): 5,478 @ $6.35 · Option exercise (M): 17,974 (derivative) @ $1.87 · Option exercise (M): 5,478 (derivative) @ $2 | EDGAR |
| 2026-07-13 | 4 | Chernett Jorey — 10% owner | Purchase (P): 15,000 @ $5.85 | EDGAR |
| 2026-07-09 | 4 | TZOUMAKAS KIMBERLY JO — Director | Grant/award (A): 17,185 @ $0 | EDGAR |
| 2026-07-09 | 4 | STOLPER MARK — Director | Grant/award (A): 25,833 @ $0 | EDGAR |
| 2026-06-24 | 4 | Chernett Jorey — 10% owner | Purchase (P): 18,000 @ $5.02 | EDGAR |
| 2026-06-09 | 4 | Podnos Yale — Chief Medical Officer | Sale (S): 23,451 @ $5.38 | EDGAR |
| 2026-06-05 | 4 | Chernett Jorey — 10% owner | Purchase (P): 12,000 @ $4.75 | EDGAR |
| 2026-05-22 | 4 | Podnos Yale — Chief Medical Officer | Other (J): 1,805 @ $4.47 | EDGAR |
| 2026-05-22 | 4 | Virnich Daniel — Chief Executive Officer | Other (J): 23,058 @ $4.47 | EDGAR |
| 2026-05-22 | 4 | Carter Robert Ross — Chief Financial Officer | Other (J): 1,604 @ $4.47 | EDGAR |
| 2026-05-21 | 4 | Chernett Jorey — 10% owner | Purchase (P): 5,000 @ $4.05 · Purchase (P): 33,500 @ $4.07 | EDGAR |
| 2026-05-20 | 4 | Chernett Jorey — 10% owner | Purchase (P): 30,000 @ $4.09 | EDGAR |
| 2026-04-23 | 4 | England Kristin — Chief Administrative Officer | Holdings only — no transactions reported | EDGAR |
| 2026-04-23 | 4 | Langsam Jeffrey — Chief Clinical Officer | Holdings only — no transactions reported | EDGAR |
| 2026-04-16 | 4 | Kaushal Mohit — Director | Sale (S): 57,286 @ $3.50 · Sale (S): 38,433 @ $3.50 | EDGAR |
| 2026-04-13 | 4 | Chernett Jorey — 10% owner | Purchase (P): 20,000 @ $3.10 | EDGAR |
| 2026-04-01 | 4 | Langsam Jeffrey — Chief Clinical Officer | Grant/award (A): 70,270 @ $0 | EDGAR |
| 2026-04-01 | 4 | England Kristin — Chief Administrative Officer | Grant/award (A): 55,743 @ $0 | EDGAR |
| 2026-04-01 | 4 | Podnos Yale — Chief Medical Officer | Grant/award (A): 66,446 @ $0 · Other (J): 16,173 @ $3.07 | EDGAR |
| 2026-04-01 | 4 | Carter Robert Ross — Chief Financial Officer | Grant/award (A): 202,914 @ $0 · Other (J): 20,320 @ $3.07 | EDGAR |
| 2026-04-01 | 4 | Virnich Daniel — Chief Executive Officer | Grant/award (A): 670,608 @ $0 · Other (J): 98,534 @ $3.07 | EDGAR |
| 2026-03-30 | 4 | Chernett Jorey — 10% owner | Purchase (P): 27,429 @ $2.96 | EDGAR |
| 2026-03-27 | 4 | Chernett Jorey — 10% owner | Purchase (P): 50,000 @ $3.15 | EDGAR |
| 2026-03-25 | 4 | Chernett Jorey — 10% owner | Purchase (P): 125,000 @ $3.11 | EDGAR |
| 2026-03-23 | 4 | Chernett Jorey — 10% owner | Purchase (P): 25,000 @ $3.35 | EDGAR |
| 2026-03-18 | 4 | Virnich Daniel — Chief Executive Officer | Other (J): 11,834 @ $3.59 | EDGAR |
| 2026-03-18 | 4 | Carter Robert Ross — Chief Financial Officer | Other (J): 1,314 @ $3.59 | EDGAR |
| 2026-03-18 | 4 | Podnos Yale — Chief Medical Officer | Other (J): 3,420 @ $3.59 | EDGAR |
| 2026-03-17 | 4 | Chernett Jorey — 10% owner | Purchase (P): 263,000 @ $2.92 · Purchase (P): 60,985 @ $3.29 · Purchase (P): 75,000 @ $3.42 | EDGAR |
| 2026-01-06 | 4/A | Carter Robert Ross — Chief Financial Officer | Other (J): 244 @ $3.67 | EDGAR |
| 2026-01-05 | 4 | Carter Robert Ross — Chief Financial Officer | Sale (S): 247 @ $3.56 | EDGAR |
| 2025-12-16 | 4 | Hively Brad — Director | Sale (S): 13,333 @ $3.77 | EDGAR |
| 2025-12-01 | 4 | Ling Gabriel — Director | Holdings only — no transactions reported | EDGAR |
| 2025-11-24 | 4 | Ling Gabriel — Director | Grant/award (A): 46,296 @ $0 · Grant/award (A): 37,037 @ $0 | EDGAR |
| 2025-11-24 | 4 | Johnson Karen Marie — Director | Grant/award (A): 47,840 @ $0 · Grant/award (A): 37,037 @ $0 | EDGAR |
| 2025-11-24 | 4 | Hively Brad — Director | Grant/award (A): 41,667 @ $0 · Grant/award (A): 32,407 @ $0 | EDGAR |
| 2025-11-24 | 4 | McGeorge Anne — Director | Grant/award (A): 67,901 @ $0 · Grant/award (A): 40,123 @ $0 | EDGAR |
| 2025-11-24 | 4 | Kaushal Mohit — Director | Grant/award (A): 50,926 @ $0 · Grant/award (A): 40,123 @ $0 | EDGAR |
| 2025-11-24 | 4 | Pacala Mark L — Director | Grant/award (A): 46,296 @ $0 · Grant/award (A): 35,494 @ $0 | EDGAR |
| 2025-11-20 | 4 | Ling Gabriel — Director | Other (J): 141,149 | EDGAR |
| 2025-11-20 | 4 | M33 Growth I L.P. — Director M33 Growth I GP LLC — Director TOI M, LLC — Director | Other (J): 590,892 · Other (J): 11,818 · Other (J): 2,500,000 | EDGAR |
| 2025-11-20 | 4 | Pacala Mark L — Director | Sale (S): 2,160 @ $4 · Sale (S): 1,210 @ $4 · Sale (S): 46,630 @ $4 | EDGAR |
Recent 8-K events — Oncology Institute, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-22 | 8-K | ? 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-13 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TOI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →